Literature DB >> 17855520

Morphogenesis of a highly replicative EGFPVP22 recombinant Marek's disease virus in cell culture.

C Denesvre1, C Blondeau, M Lemesle, Y Le Vern, D Vautherot, P Roingeard, J F Vautherot.   

Abstract

Marek's disease virus (MDV) is an alphaherpesvirus for which infection is strictly cell associated in permissive cell culture systems. In contrast to most other alphaherpesviruses, no comprehensive ultrastructural study has been published to date describing the different stages of MDV morphogenesis. To circumvent problems linked to nonsynchronized infection and low infectivity titers, we generated a recombinant MDV expressing an enhanced green fluorescent protein fused to VP22, a major tegument protein that is not implicated in virion morphogenesis. Growth of this recombinant virus in cell culture was decreased threefold compared to that of the parental Bac20 virus, but this mutant was still highly replicative. The recombinant virus allowed us to select infected cells by cell-sorting cytometry at late stages of infection for subsequent transmission electron microscopy analysis. Under these conditions, all of the stages of assembly and virion morphogenesis could be observed except extracellular enveloped virions, even at the cell surface. We observed 10-fold fewer naked cytoplasmic capsids than nuclear capsids, and intracellular enveloped virions were very rare. The partial envelopment of capsids in the cytoplasm supports the hypothesis of the acquisition of the final envelope in this cellular compartment. We demonstrate for the first time that, compared to other alphaherpesviruses, MDV seems deficient in three crucial steps of viral morphogenesis, i.e., release from the nucleus, secondary envelopment, and the exocytosis process. The discrepancy between the efficiency with which this MDV mutant spreads in cell culture and the relatively inefficient process of its envelopment and virion release raises the question of the MDV cell-to-cell spreading mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855520      PMCID: PMC2168996          DOI: 10.1128/JVI.01177-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  A simple and rapid method for preparation of viral DNA from cell associated cytomegalovirus.

Authors:  C Sinzger; J Knapp; K Schmidt; M Kahl; G Jahn
Journal:  J Virol Methods       Date:  1999-08       Impact factor: 2.014

2.  The history and biology of Marek's disease virus.

Authors:  P M Biggs
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 3.  Herpesvirus assembly and egress.

Authors:  Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth.

Authors:  Fabien Dorange; B Karsten Tischer; Jean-François Vautherot; Nikolaus Osterrieder
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 5.  Directed egress of animal viruses promotes cell-to-cell spread.

Authors:  David C Johnson; Mary T Huber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown.

Authors:  Daniel Schumacher; B Karsten Tischer; Sascha Trapp; Nikolaus Osterrieder
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  The pseudorabies virus VP22 homologue (UL49) is dispensable for virus growth in vitro and has no effect on virulence and neuronal spread in rodents.

Authors:  T del Rio; H C Werner; L W Enquist
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

8.  Egress of alphaherpesviruses: comparative ultrastructural study.

Authors:  H Granzow; B G Klupp; W Fuchs; J Veits; N Osterrieder; T C Mettenleiter
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

9.  Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.

Authors:  Tadahiko Igakura; Jane C Stinchcombe; Peter K C Goon; Graham P Taylor; Jonathan N Weber; Gillian M Griffiths; Yuetsu Tanaka; Mitsuhiro Osame; Charles R M Bangham
Journal:  Science       Date:  2003-02-13       Impact factor: 47.728

10.  Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant.

Authors:  D Schumacher; B K Tischer; W Fuchs; N Osterrieder
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

View more
  16 in total

1.  Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.

Authors:  Stephen J Spatz; Cary Rue; Daniel Schumacher; Nikolaus Osterrieder
Journal:  Virus Genes       Date:  2008-05-31       Impact factor: 2.332

2.  Fluorescently tagged pUL47 of Marek's disease virus reveals differential tissue expression of the tegument protein in vivo.

Authors:  Keith W Jarosinski; Sina Arndt; Benedikt B Kaufer; Nikolaus Osterrieder
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

3.  Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.

Authors:  Johnathan Storlie; John E Carpenter; Wallen Jackson; Charles Grose
Journal:  Virology       Date:  2008-10-26       Impact factor: 3.616

4.  Marek's disease virus undergoes complete morphogenesis after reactivation in a T-lymphoblastoid cell line transformed by recombinant fluorescent marker virus.

Authors:  Caroline Denesvre; Sylvie Rémy; Laetitia Trapp-Fragnet; Lorraine P Smith; Sonia Georgeault; Jean-François Vautherot; Venugopal Nair
Journal:  J Gen Virol       Date:  2015-11-26       Impact factor: 3.891

5.  A virulent bioluminescent and fluorescent dual-reporter Marek's disease virus unveils an alternative spreading pathway in addition to cell-to-cell contact.

Authors:  Abdallah Harmache
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

6.  Functional homologies between avian and human alphaherpesvirus VP22 proteins in cell-to-cell spreading as revealed by a new cis-complementation assay.

Authors:  C Blondeau; D Marc; K Courvoisier; J-F Vautherot; C Denesvre
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

7.  The Tegument Protein pUL47 of Marek's Disease Virus Is Necessary for Horizontal Transmission and Is Important for Expression of Glycoprotein gC.

Authors:  Aurélien Chuard; Katia Courvoisier-Guyader; Sylvie Rémy; Stephen Spatz; Caroline Denesvre; David Pasdeloup
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

8.  Fluorescent tagging of VP22 in N-terminus reveals that VP22 favors Marek's disease virus (MDV) virulence in chickens and allows morphogenesis study in MD tumor cells.

Authors:  Sylvie Rémy; Caroline Blondeau; Yves Le Vern; Monique Lemesle; Jean-François Vautherot; Caroline Denesvre
Journal:  Vet Res       Date:  2013-12-21       Impact factor: 3.683

9.  The Marek's disease virus (MDV) protein encoded by the UL17 ortholog is essential for virus growth.

Authors:  Najat Chbab; Danièle Chabanne-Vautherot; Annick Francineau; Nikolaus Osterrieder; Caroline Denesvre; Jean-François Vautherot
Journal:  Vet Res       Date:  2009-03-14       Impact factor: 3.683

10.  Rho-ROCK and Rac-PAK signaling pathways have opposing effects on the cell-to-cell spread of Marek's Disease Virus.

Authors:  Nicolas Richerioux; Caroline Blondeau; Agnès Wiedemann; Sylvie Rémy; Jean-François Vautherot; Caroline Denesvre
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.